Bio-Technology General Euflexxa 1% Sodium Hyaluronate

Country: Սինգապուր

language: անգլերեն

source: HSA (Health Sciences Authority)

MAH:

FERRING PHARMACEUTICALS PRIVATE LIMITED

class:

Class D medical device

manufactured_by:

Bio-Technology General (Israel) Ltd.

therapeutic_area:

Orthopaedics

therapeutic_indication:

EUFLEXXA is indicated for the treatment of pain caused by osteoarthritis of the knee, hip, temporomandibular, carpometacarpal, shoulder and ankle joints. EUFLEXXA aids in lubrication of the joint, allows for greater mobility and flexibility of the treated joint, and reduces pain in the affected joint.

leaflet_short:

Device System Info:[Sterile Medical Device], EUFLEXXA is packed in a single-use, aseptically-filled disposable sterile 2.25 ml syringe (nominal volume) containing either 1 ml or 2 ml of 1% microbial fermentation-derived NaHA in phosphate-buffered saline; Models: Euflexxa 1% Sodium Hyaluronate - 3 x 2ml, Euflexxa 1% Sodium Hyaluronate - 1 x 2ml

authorization_date:

2017-04-28